ASH Presents: An Exclusive Preview of the 2016 Meeting on Hematologic Malignancies
"Still haven't registered for the 2016 ASH Meeting on Hematologic Malignancies? Join us for this special webinar preview of what will be presented next month! Listen to three program speakers as they give you an exclusive sneak-peek into what they will present at the meeting. Then participate in a special Q&A session to find out why you should join us in Chicago in September!
This webinar will feature a special preview of presentations by three distinguished presenters from the upcoming meeting, structured in the \"How I Treat\" format to best convey how you can immediately apply evidenced-based treatment approaches to practice:
Dr. David Steensma: How I treat lower-risk myelodysplastic syndromes (MDS)
Dr. Ruben Mesa: How I Treat Myelofibrosis Patients Who Have Failed Ruxolitinib
Dr. John P. Leonard: How I Treat Diffuse Large B-Cell and Mediastinal Large Cell Lymphomas
The ASH Meeting on Hematologic Malignancies, will be held in Chicago, IL, September 16-17. This meeting is a unique opportunity to join colleagues and top experts in treatment of hematologic malignancies in an intimate, smaller-meeting setting and discuss the latest drug developments and most relevant research findings advancing patient care today. Visit www.hematology.org/malignancies to review speaker line-up and program schedule and to register.